Stifel analyst Stephen Willey downgraded Lexicon Pharmaceuticals (NASDAQ: LXRX) from to Hold with a price target of $4.00 (from $10.00).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE